生物性骨材市场规模、份额、成长分析（按产品类型、按类型、按应用、按最终用户、按地区）- 产业预测 2025-2032

2023 年全球生物性骨材市场规模价值 83 亿美元，预计将从 2024 年的 87.8 亿美元成长到 2032 年的 137.9 亿美元，预测期内（2025-2032 年）的复合年增长率为 5.8%。

生物性骨材市场涵盖促进肌肉骨骼疾病治癒的产品，预计由于再生医学的进步、人口老化和整形外科手术的增加，该市场将经历显着增长。主要产品包括干细胞、骨移植和 PRP（富含血浆的血小板）疗法。然而，严格的监管核准、缺乏标准化以及治疗成本高等挑战可能会阻碍市场扩张。儘管存在这些障碍，但由于应用机会的激增、研发力度的加强以及个人化医疗趋势的日益增强，该领域有望蓬勃发展。因此，预计整个预测期内市场动态将经历显着增长，反映肌肉骨骼健康治疗方案的动态和不断发展的前景。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管格局
• 案例研究

生物性骨材市场规模（按产品类型和复合年增长率） (2025-2032)

• 市场概览
• 去矿物质骨基质（DBM）
• 同种异体移植
• 骨形成蛋白（BMP）
• 关节内粘稠补充疗法
• 合成骨替代物
• 干细胞疗法

生物性骨材市场规模（按类型及复合年增长率） (2025-2032)

• 市场概览
• 膝盖
• 踝
• 时髦的
• 手腕和肩膀
• 脊椎
• 其他的

生物性骨材市场规模（按应用和复合年增长率） (2025-2032)

• 市场概览
• 骨关节炎和骨关节炎
• 脊椎融合手术
• 骨折恢復
• 软组织损伤
• 颚颜面和牙科应用

生物性骨材市场规模（按最终用户和复合年增长率） (2025-2032)

• 市场概览
• 医院及门诊中心
• 研究和学术机构
• 牙医诊所

生物性骨材市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Stryker Corporation（USA）
• Medtronic plc（Ireland）
• Zimmer Biomet Holdings, Inc.（USA）
• DePuy Synthes（Johnson & Johnson）（USA）
• Bioventus LLC（USA）
• Arthrex, Inc.（USA）
• NuVasive, Inc.（USA）
• Orthofix International NV（Netherlands）
• Globus Medical, Inc.（USA）
• Kuros Biosciences AG（Switzerland）
• Xtant Medical Holdings, Inc.（USA）
• Harvest Technologies Corporation（USA）
• Wright Medical Group NV（Netherlands）
• Smith & Nephew plc（UK）
• Bone Biologics Corp.（USA）
• Sano Orthopedics（USA）

结论和建议

Global Orthobiologics Market size was valued at USD 8.3 billion in 2023 and is poised to grow from USD 8.78 billion in 2024 to USD 13.79 billion by 2032, growing at a CAGR of 5.8% during the forecast period (2025-2032).

The orthobiologics market, encompassing products that enhance the healing of musculoskeletal conditions, is poised for significant growth driven by advancements in regenerative medicine, an aging population, and increasing orthopedic procedures. Key offerings include stem cells, bone grafts, and PRP (plasma-rich-platelet) therapies. However, challenges such as stringent regulatory approvals, lack of standardization, and high treatment costs may hinder market expansion. Despite these obstacles, the sector is set to flourish due to burgeoning opportunities in applications, increased research and development efforts, and a rising trend towards personalized medicine. As a result, the orthobiologics market is expected to experience notable growth through the forecast period, reflecting a dynamic and evolving landscape in treatment options for musculoskeletal health.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Orthobiologics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Orthobiologics Market Segments Analysis

Global Orthobiologics Market is segmented by Product Type, Type, Application, End-user and region. Based on Product Type, the market is segmented into Demineralized Bone Matrix (DBM), Allograft, Bone morphogenetic protein (BMP), Viscosupplementation, Synthetic bone substitutes and Stem cell therapy. Based on Type, the market is segmented into Knee, Ankle, Hip, Wrist & Shoulder, Spine and Others. Based on Application, the market is segmented into Osteoarthritis & Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries and Maxillofacial & Dental Applications. Based on End-user, the market is segmented into Hospitals & Ambulatory Centers, Research & Academic Institute and Dental Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Orthobiologics Market

The global orthobiologics market is significantly driven by advancements in modern technologies and research and development efforts. Innovations in platelet-rich plasma (PRP), stem cell therapies, and various related techniques are enhancing the availability, access, and effectiveness of orthobiologics, thereby fueling market expansion. Furthermore, ongoing research and clinical trials are paving the way for the introduction of new treatment methods and products. These innovations not only promote faster healing but also contribute to better overall recovery outcomes, solidifying the positive trajectory of the orthobiologics market and attracting increasing interest from both healthcare providers and patients.

Restraints in the Global Orthobiologics Market

The expansion of the global orthobiologics market faces significant challenges primarily due to the demand for comprehensive research and the variability of outcomes associated with these therapies. Although advancements and promising developments in this field are evident, the insufficiency of thorough clinical studies demonstrating the effectiveness of various orthobiologics may limit their acceptance among healthcare providers. Furthermore, the inconsistency in results observed across multiple studies can foster doubt regarding the efficacy of certain products, ultimately influencing their widespread adoption and usage within medical practices. As a result, these factors collectively pose a restraint on market growth.

Market Trends of the Global Orthobiologics Market

The Global Orthobiologics market is witnessing a notable trend towards the increased adoption of Platelet-Rich Plasma (PRP) treatments, driven by its efficacy in treating joint pain, soft tissue injuries, and enhancing post-surgical recovery. This regenerative application of PRP is gaining traction among healthcare professionals and patients alike, fueled by the growing focus on minimally invasive procedures. Furthermore, initiatives aimed at standardizing PRP preparation and administration protocols are enhancing its credibility and reliability, leading to improved outcomes. As a result, this trend is expected to bolster the overall market growth, positioning PRP as a pivotal component of modern orthobiologic therapies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Orthobiologics Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Demineralized Bone Matrix (DBM)
• Allograft
• Bone morphogenetic protein (BMP)
• Viscosupplementation
• Synthetic bone substitutes
• Stem cell therapy

Global Orthobiologics Market Size by Type & CAGR (2025-2032)

• Market Overview
• Knee
• Ankle
• Hip
• Wrist & Shoulder
• Spine
• Others

Global Orthobiologics Market Size by Application & CAGR (2025-2032)

• Market Overview
• Osteoarthritis & Degenerative Arthritis
• Spinal Fusion
• Fracture Recovery
• Soft Tissue Injuries
• Maxillofacial & Dental Applications

Global Orthobiologics Market Size by End-user & CAGR (2025-2032)

• Market Overview
• Hospitals & Ambulatory Centers
• Research & Academic Institute
• Dental Clinics

Global Orthobiologics Market Size & CAGR (2025-2032)

• North America (Product Type, Type, Application, End-user)
  • US
  • Canada
• Europe (Product Type, Type, Application, End-user)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Type, Application, End-user)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Type, Application, End-user)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Type, Application, End-user)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DePuy Synthes (Johnson & Johnson) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuVasive, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthofix International N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Globus Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kuros Biosciences AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xtant Medical Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Harvest Technologies Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wright Medical Group N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bone Biologics Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sano Orthopedics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations